EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
You can subscribe to receive the EAHP EU Monitor by email here.
Hospital pharmacists from across Europe gather in Prague for EAHP General AssemblyHospital pharmacists from across Europe are gathering in Prague today (9th June) for the annual General Assembly of the European Association of Hospital Pharmacists (EAHP). Topics on the agenda include implementation of the 44 European Statements of Hospital Pharmacy and the development of a common training framework for hospital pharmacy in Europe.
More information here.
Delegates to the Sixty-ninth World Health Assembly have agreed a range of measures aimed at addressing the global shortage of medicines and vaccines, especially for children.
Delegates agreed to develop ways to forecast, avert and reduce shortages. These include notification systems, better ways of monitoring supply and demand, improving financial management of procurement systems to prevent funding shortfalls, and improving affordability through price negotiations and voluntary or compulsory licensing of high-priced medicines.
Other highlights from the World Health Assembly meeting include the adoption of a “WHO Framework on Integrated, People-Centred Health Services”, which calls for a fundamental shift in the way health services are funded, managed and delivered. Delegates requested WHO to develop indicators to track progress toward integrated people-centred health services.
More information here. The full text of the agreed resolution is available here.
(1)(1).jpg)
Commission launches 4 consultations on application of clinical trials regulationThe European Commission has opened 4 separate public consultations, each examining a distinct issue, or set of issues, related to implementation of EU Regulation 536/2014 (“the Clinical Trials Regulation”).
1. Consultation on risk proportionate approaches to clinical trial regulation
The first consultation seeks stakeholder opinions on how best to apply the “risk proportionate” approach to regulation of clinical trials envisaged in Regulation 536/2014. Regulation 536/2014 provides for less stringent rules or adaptations with regards to monitoring, traceability of the Investigational Medicinal Product (IMP) and content of the Trial Master File (TMF), to those clinical trials which pose only a minimal additional risk to subject safety (as defined in Article 2(3) of the Regulation) compared to normal clinical practice. The consultation covers such issues as how identification of risk levels should be conducted and the application of risk proportionate approaches to safety report. The deadline for response is 31 August 2016.
2. Public consultation on “Summary of Clinical Trial Results for Laypersons”
A second consultation interrogates the application of Article 37 of the Clinical trial Regulation (EU) No 536/2014 which requires that sponsors provide a summary of clinical trial results in the EU Portal and Database, in a format understandable to laypersons.
The consultation seeks stakeholder opinion on the recommendations formed by an expert group on what primary elements should be covered in a lay summary, and other guidelines such as format, language and a recommended template.
The deadline for response is 31 August 2016.
3. Definition of Investigational Medicinal Products (IMPs) and use of Auxiliary Medicinal Products (AMPs)
A third consultation examines the definition of “Investigational Medicinal Product” with a particular focus given to how common understanding about the term and concept of “Auxiliary Medicinal Products” can be established. Different types of AMP are explored, such as rescue medication and challenge agents.
The deadline for response is 31 August 2016.
4. Public consultation on the revision of “Ethical Considerations for Clinical Trials on Medicinal products conducted with Minors”
A fourth consultation is now published exploring aspects of change that Regulation (EU) No 536/2014 ushers in in respect to the participation of children in clinical trials. This includes greater emphasis on understanding informed consent as a continual process, new recommendations in respect to consent in emergency situations and the provision of age appropriate information.
The deadline for response is 31 August 2016.
All four consultations are available here and here.
In other clinical trial news, the European Medicines Agency has announced a review of the guidelines that describe first-inhuman clinical trials and the data needed to enable their appropriate design and allow initiation. This is being done in cooperation with the European Commission and the Member States of the European Union (EU).
The review will identify which areas may need to be revised in the light of the tragic incident which took place during a Phase I first-in-human clincial trial in Rennes, France, in January 2016. The trial led to the death of one participant and hospitalisation of five others.
More information here.
EJHP: Cleaning validation for blister packaging machines in an Austrian pharmacyThe Online First edition of the European Journal of Hospital Pharmacy this week published an original study investigating the cleaning procedures of blister machines in an Austrian hospital pharmacy.
Article here.
